- Home
- FSFG vs BDTX Comparison
FSFG vs BDTX Comparison
Compare FSFG & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSFG
- BDTX
- Stock Information
- Founded
- FSFG 2008
- BDTX 2014
- Country
- FSFG United States
- BDTX United States
- Employees
- FSFG N/A
- BDTX N/A
- Industry
- FSFG Savings Institutions
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSFG Finance
- BDTX Health Care
- Exchange
- FSFG Nasdaq
- BDTX Nasdaq
- Market Cap
- FSFG 216.6M
- BDTX 181.4M
- IPO Year
- FSFG 2008
- BDTX 2020
- Fundamental
- Price
- FSFG $29.65
- BDTX $3.80
- Analyst Decision
- FSFG Strong Buy
- BDTX Strong Buy
- Analyst Count
- FSFG 3
- BDTX 5
- Target Price
- FSFG $31.50
- BDTX $10.40
- AVG Volume (30 Days)
- FSFG 23.6K
- BDTX 904.0K
- Earning Date
- FSFG 10-29-2025
- BDTX 11-05-2025
- Dividend Yield
- FSFG 2.16%
- BDTX N/A
- EPS Growth
- FSFG 130.94
- BDTX N/A
- EPS
- FSFG 3.10
- BDTX 0.25
- Revenue
- FSFG $79,674,000.00
- BDTX $70,000,000.00
- Revenue This Year
- FSFG N/A
- BDTX N/A
- Revenue Next Year
- FSFG $7.37
- BDTX N/A
- P/E Ratio
- FSFG $9.55
- BDTX $15.26
- Revenue Growth
- FSFG 10.53
- BDTX N/A
- 52 Week Low
- FSFG $21.63
- BDTX $1.20
- 52 Week High
- FSFG $33.00
- BDTX $4.45
- Technical
- Relative Strength Index (RSI)
- FSFG 46.77
- BDTX 49.08
- Support Level
- FSFG $29.36
- BDTX $3.67
- Resistance Level
- FSFG $31.17
- BDTX $4.08
- Average True Range (ATR)
- FSFG 0.71
- BDTX 0.24
- MACD
- FSFG -0.21
- BDTX -0.06
- Stochastic Oscillator
- FSFG 19.32
- BDTX 10.26
About FSFG First Savings Financial Group Inc.
First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.